These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14509984)

  • 1. [Aspects for long-term anti-viral therapy in treatment of chronic hepatitis B].
    Wang H
    Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):367-8. PubMed ID: 14509984
    [No Abstract]   [Full Text] [Related]  

  • 2. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
    Yokosuka O
    J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy.
    Suzuki F; Tsubota A; Akuta N; Someya T; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Miyakawa Y; Kumada H
    J Gastroenterol; 2002; 37(11):922-7. PubMed ID: 12483247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One two tandem of lamivudine and inferferon might work for patients with chronic hepatitis B who failed inferferon monotherapy.
    Kaplan DD; Reddy KR
    Am J Gastroenterol; 2002 Sep; 97(9):2465-7. PubMed ID: 12358276
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon/long-term lamivudine combination therapy in anti-HBe positive chronic hepatitis B patients.
    Nikolaidis NL; Giouleme OI; Tziomalos KA; Saveriadis AS; Grammatikos N; Doukelis P; Voutsas AD; Vassiliadis T; Patsiaoura K; Orfanou-Koumerkeridou E; Balaska A; Eugenidis NP
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1721-5. PubMed ID: 16246192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus with primary resistance to adefovir.
    Chang TT; Lai CL
    N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug resistance after lamivudine therapy for chronic hepatitis B.
    Sarrecchia C; Volpi A; Sordillo P; Andreoni M
    Int J Infect Dis; 2009 May; 13(3):e133-4. PubMed ID: 18990599
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy of chronic hepatitis B: new goals and new treatments.
    Mauss S
    Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract]   [Full Text] [Related]  

  • 10. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
    Aloman C; Wands JR
    Hepatology; 2003 Dec; 38(6):1584-7. PubMed ID: 14655682
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
    Benhamou Y
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
    [No Abstract]   [Full Text] [Related]  

  • 12. [Managing resistance to analogue antiviral drugs in a decompensated cirrhosis patient].
    Zarski JP
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S20-1. PubMed ID: 17075491
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH; Han KH; Hong SP; Lee HW; Lee KS; Kim SO; Shin JE; Ahn SH; Chon CY; Moon YM
    Antivir Ther; 2006; 11(4):447-55. PubMed ID: 16856618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability of hepatitis B virus and response to antiviral treatments: searching for a bigger picture.
    Yuen LK; Locarnini SA
    J Hepatol; 2009 Mar; 50(3):445-8. PubMed ID: 19152982
    [No Abstract]   [Full Text] [Related]  

  • 15. Adefovir for lamivudine resistant HBV: more than meets the eye.
    Di Marco V; Craxì A
    J Hepatol; 2007 Oct; 47(4):618-9; author reply 619-20. PubMed ID: 17697727
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
    Moskovitz DN; Osiowy C; Giles E; Tomlinson G; Heathcote EJ
    J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
    Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
    Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and problems in combination therapy using lamivudine and interferon for chronic hepatitis B].
    Saito T; Watanabe H; Togashi H; Kawata S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():326-30. PubMed ID: 15453339
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analyzing clinical character of patients resistant to lamivudine with chronic hepatitis B with YMDD mutations or non-YMDD mutations].
    Yang DH; Xie YJ; Liang WF; Zhao NF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):496-7. PubMed ID: 15329216
    [No Abstract]   [Full Text] [Related]  

  • 20. Remission of breakthrough hepatitis in chronic hepatitis B patients on lamivudine.
    Koike K
    J Gastroenterol; 2002; 37(11):988-90. PubMed ID: 12483259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.